| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Alland Leila is a Director at ABEONA THERAPEUTICS INC. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 15 sells.
Estimated insider holdings value: $928K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | ABEO Abeona Therapeutics Inc. | Director | Buy | 11,000 | $4.71 | $51,799.00 | +15.3% | +7.6% | +32.6% | |
| Sep 27, 2023 | ABEO Abeona Therapeutics Inc. | Director | Sell | 7,246 | $3.90 | $28,269.54 | -9.2% | +28.5% | +49.7% | |
| Sep 15, 2023 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 6,291 | $6.62 | $41,646.42 | -12.1% | -66.0% | -77.5% | |
| Sep 9, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 100 | $30.25 | $3,025.00 | -100% | -13.7% | -52.8% | |
| Sep 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 3,900 | $30.25 | $117,975.00 | -100% | -20.2% | -51.4% | |
| Aug 9, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,471 | $34.04 | $152,202.15 | -68.8% | -30.0% | -55.6% | |
| Jul 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $32.30 | $129,213.11 | -66.1% | -7.2% | -49.8% | |
| Jun 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $33.60 | $134,386.84 | -74.5% | -13.7% | -67.5% | |
| May 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $34.83 | $139,308.88 | -96.2% | +4.1% | -63.5% | |
| Apr 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $33.86 | $135,444.59 | -99.3% | -2.6% | -35.4% |